Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will incubate local biotechs starting with Puhe BioPharma and Youngen Technology.

Bayer (XTRA:BAYN) shares have seen some interesting moves over the past month, reflecting a blend of market sentiment and current company fundamentals. Investors may be watching recent performance ...

Amid a rise in misinformation and pseudoscientific beliefs, a new corporate push from Bayer seeks to remind Americans of the power of actual science. The “Science Delivers” campaign, which launched on ...

Bayer AG BAYRY reported third-quarter 2025 core earnings of 17 cents per American Depositary Receipt (ADR), which comfortably beat the Zacks Consensus Estimate of 13 cents per ADR. The company ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Nov 19 (Reuters) - The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's (BAYGn.DE), opens new tab drug for patients with a form of lung cancer that has advanced or ...

Everything you need to know about the Manchester City vs Bayer Leverkusen matchUEFA Champions League: What time and on which channel to watch Manchester City vs Bayer Leverkusen?Manchester City hosts ...

Galmed (GLMD) announced results from its joint research with Virginia Commonwealth University, or VCU, evaluating Aramchol’s effect on overcoming drug resistance in gastrointestinal cancers. The ...

At the end of July, and before the company’s quarterly earnings report coming on Aug. 6, Bayer announced it has allocated an additional $1.37 billion to its efforts around glyphosate litigation. The ...

After launching an initial “frontrunner” a group in Illinois, Bayer says its Crop Science division is ready to roll out the company’s new operating model, Dynamic Shared Ownership (as it’s known ...